NO20025898L - Fremgangsmater og tilhorende preparater for a oke overlevelsen av akvatiske dyr og andre dyr som utsettes for et akvatisk virus, birnavirus eller annet RNAvirus - Google Patents

Fremgangsmater og tilhorende preparater for a oke overlevelsen av akvatiske dyr og andre dyr som utsettes for et akvatisk virus, birnavirus eller annet RNAvirus

Info

Publication number
NO20025898L
NO20025898L NO20025898A NO20025898A NO20025898L NO 20025898 L NO20025898 L NO 20025898L NO 20025898 A NO20025898 A NO 20025898A NO 20025898 A NO20025898 A NO 20025898A NO 20025898 L NO20025898 L NO 20025898L
Authority
NO
Norway
Prior art keywords
aquatic
animals
virus
survival
infection
Prior art date
Application number
NO20025898A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025898D0 (no
Inventor
Ana Maria Sandino Garcia
Geraldine Mlynarz Zylberberg
Original Assignee
Geraldine Mlynarz Zylberberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42140308&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20025898(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Geraldine Mlynarz Zylberberg filed Critical Geraldine Mlynarz Zylberberg
Publication of NO20025898D0 publication Critical patent/NO20025898D0/no
Publication of NO20025898L publication Critical patent/NO20025898L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20025898A 2001-12-07 2002-12-09 Fremgangsmater og tilhorende preparater for a oke overlevelsen av akvatiske dyr og andre dyr som utsettes for et akvatisk virus, birnavirus eller annet RNAvirus NO20025898L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33668401P 2001-12-07 2001-12-07

Publications (2)

Publication Number Publication Date
NO20025898D0 NO20025898D0 (no) 2002-12-09
NO20025898L true NO20025898L (no) 2003-06-10

Family

ID=42140308

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20025898A NO20025898L (no) 2001-12-07 2002-12-09 Fremgangsmater og tilhorende preparater for a oke overlevelsen av akvatiske dyr og andre dyr som utsettes for et akvatisk virus, birnavirus eller annet RNAvirus
NO20110661A NO335129B1 (no) 2001-12-07 2011-05-03 Anvendelse av neomycin for fremstilling av et medikament for behandling eller forebygging av infeksjon med infeksiøst pankreatisk nekrose virus (IPNV) hos akvatiske dyr

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20110661A NO335129B1 (no) 2001-12-07 2011-05-03 Anvendelse av neomycin for fremstilling av et medikament for behandling eller forebygging av infeksjon med infeksiøst pankreatisk nekrose virus (IPNV) hos akvatiske dyr

Country Status (9)

Country Link
US (2) US7652050B2 (de)
EP (2) EP2193792B1 (de)
AT (2) ATE465730T1 (de)
CA (1) CA2428703A1 (de)
CL (1) CL2008003293A1 (de)
DE (1) DE60236136D1 (de)
DK (2) DK2193792T3 (de)
ES (2) ES2345244T3 (de)
NO (2) NO20025898L (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006286809B2 (en) * 2005-08-29 2011-07-07 Novartis Tiergesundheit Ag Use of oxazole derivatives for controlling fish parasites
NO20055541L (no) * 2005-11-23 2007-05-24 Berge Biomed As Use of fatty acid analogues
CA2801844C (en) * 2010-06-08 2015-08-11 Laboratorio De Diagnostico Gam, S.A. Use of 1-beta-d-ribofuranosyl-1h-1,2,4-triazole-3-carboxamide for the treatment of infectious salmon anemia
WO2013059168A2 (en) * 2011-10-21 2013-04-25 Research Development Foundation Espirito santo virus and methods for detecting and preventing infection with the same
KR101540696B1 (ko) 2014-12-12 2015-08-03 대한민국 바이러스 내성 넙치 육종 방법
US20250057849A1 (en) * 2021-12-22 2025-02-20 Cj Cheiljedang Corporation Antiviral composition comprising nucleoside analogues derived from nucleic acid and pharmaceutically acceptable salt thereof
CN117281905A (zh) * 2023-09-14 2023-12-26 中国水产科学研究院黑龙江水产研究所 磷脂酶a2作为靶点在防治传染性造血器官坏死病毒感染中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878047A (en) 1973-02-02 1975-04-15 Upjohn Co Process for production of AT-125
US4225720A (en) 1978-05-15 1980-09-30 The Upjohn Company Purification of AT-125
USRE31578E (en) 1978-05-15 1984-05-01 The Upjohn Company α(Substituted) amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
US4232164A (en) 1978-05-15 1980-11-04 The Upjohn Company Purification of AT-125
US4256898A (en) 1978-05-15 1981-03-17 The Upjohn Company α(substituted) Amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
JPS5793968A (en) * 1980-11-11 1982-06-11 Sankyo Co Ltd Carbamic acid ester and insecticide containing the same
US4843087A (en) 1983-08-29 1989-06-27 Sterling Drug Inc. Di-heterocyclic compounds and their use as antiviral agents
US5087639A (en) * 1988-11-02 1992-02-11 The Upjohn Company Preventing CNS toxicity of acivicin when used with four large neutral amino acids
US5316769A (en) 1989-12-27 1994-05-31 Fujisawa Pharmaceutical Co., Ltd. Drug for preventing and treating fish diseases
US5349068A (en) 1992-04-15 1994-09-20 Sterling Winthrop Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US20020058911A1 (en) * 1999-05-07 2002-05-16 Paul Gilson Support frame for an embolic protection device
US6540722B1 (en) * 1999-12-30 2003-04-01 Advanced Cardiovascular Systems, Inc. Embolic protection devices
US6689151B2 (en) * 2001-01-25 2004-02-10 Scimed Life Systems, Inc. Variable wall thickness for delivery sheath housing
WO2003055413A2 (en) * 2001-12-21 2003-07-10 Salviac Limited A support frame for an embolic protection device
US8182508B2 (en) * 2005-10-04 2012-05-22 Cook Medical Technologies Llc Embolic protection device
US20070239198A1 (en) * 2006-04-03 2007-10-11 Boston Scientific Scimed, Inc. Filter and wire with distal isolation

Also Published As

Publication number Publication date
DK2193792T3 (da) 2012-01-02
EP1317923A2 (de) 2003-06-11
EP2193792B1 (de) 2011-08-31
CA2428703A1 (en) 2004-11-14
CL2008003293A1 (es) 2009-03-20
US7652050B2 (en) 2010-01-26
EP1317923B1 (de) 2010-04-28
ATE522212T1 (de) 2011-09-15
US20030191169A1 (en) 2003-10-09
DE60236136D1 (de) 2010-06-10
DK1317923T3 (da) 2010-08-09
NO20110661L (no) 2003-06-10
NO335129B1 (no) 2014-09-22
ES2372915T3 (es) 2012-01-27
EP2193792A1 (de) 2010-06-09
ES2345244T3 (es) 2010-09-20
NO20025898D0 (no) 2002-12-09
US8044031B2 (en) 2011-10-25
US20100204290A1 (en) 2010-08-12
ATE465730T1 (de) 2010-05-15
EP1317923A3 (de) 2003-09-10

Similar Documents

Publication Publication Date Title
Ayala et al. A review of pathogen transmission at the backyard chicken–wild bird interface
Gudding et al. A history of fish vaccination: science-based disease prevention in aquaculture
Timi et al. A century of parasitology in fisheries and aquaculture
CL2008003293A1 (es) Uso de neomicina para preparar un medicamento para tratar y prevenir una infección causada por un virus birnaviridae en un animal acuatico (div. sol. n°2800-02)
CY1108533T1 (el) Ανθελμινθικες στοματικες ομοιογενεις κτηνιατρικες παστες
DK1105497T3 (da) Koldadapterede hesteinfluenzavira
RU2010116187A (ru) Способ получения вируса гриппа
EA200800209A1 (ru) N-тиоантраниламидные соединения и их применение в качестве пестицидов
DE69820265D1 (de) Für den vogelembryo geeignete multivalente impfstoffe
EA200500610A1 (ru) Композиция для лечения инфекции, вызываемой вирусами семейств flaviviridae
RU2016129272A (ru) Применение изоксазолиновых соединений на домашней птице
Wanaratana et al. The potential of house flies to act as a vector of avian influenza subtype H5N1 under experimental conditions
WO2001060849A3 (en) Cold-adapted equine influenza viruses
Muhammad et al. Effect of physico-chemical factors on survival of avian influenza virus (H7N3 type)
Godwin et al. Pilchard orthomyxovirus (POMV). II. Causative agent of salmon orthomyxoviral necrosis, a new disease of farmed Atlantic salmon Salmo salar
He et al. Experimental evidence of effective disinfectant to control the transmission of Micropterus salmoides rhabdovirus
Mishra et al. Studies on the pathogenicity of Newcastle disease virus isolates in guinea fowl
Kim et al. Effects of a broad-spectrum caspase inhibitor, Z-VAD (OMe)-FMK, on viral hemorrhagic septicemia virus (VHSV) infection-mediated apoptosis and viral replication
US7140323B2 (en) Reducing the level of bacteria and viruses in aquaculture
BRPI0514476A (pt) inibidores da formação de cápsideo hiv-1: aril aminometil tiazol uréias substituìdas e análogos destas
López‐Vázquez et al. In vivo study of viral haemorrhagic septicaemia virus and infectious pancreatic necrosis virus coexistence in Senegalese sole (Solea senegalensis)
RU2019137459A (ru) Вакцины на основе реовирусов птиц
Roy et al. Ontogenetic profile of Antiviral Mx gene and its role in innate immunity in Mrigal, Cirrhinus mrigala (Hamilton 1822)
Agrebi et al. Gamma-Ray Inactivation of Betanodavirus: Antigen Preservation and Vaccine Potential
AU2014400580A1 (en) Agent with antiviral properties for preventing or treating individuals exposed to a virus of the Birnaviridae family

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA

FC2A Withdrawal, rejection or dismissal of laid open patent application